Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioRestorative Therapies (BRTX) Non-Current Deferred Tax Liability (2016 - 2020)

BioRestorative Therapies (BRTX) has disclosed Non-Current Deferred Tax Liability for 4 consecutive years, with $26000.0 as the latest value for Q4 2019.

  • For the quarter ending Q4 2019, Non-Current Deferred Tax Liability rose 23.81% year-over-year to $26000.0, compared with a TTM value of $26000.0 through Dec 2019, up 23.81%, and an annual FY2019 reading of $26000.0, up 23.81% over the prior year.
  • Non-Current Deferred Tax Liability was $26000.0 for Q4 2019 at BioRestorative Therapies, up from $21000.0 in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $115000.0 in Q4 2016 and bottomed at $21000.0 in Q4 2018.
  • Average Non-Current Deferred Tax Liability over 4 years is $53000.0, with a median of $38000.0 recorded in 2017.
  • The sharpest move saw Non-Current Deferred Tax Liability crashed 58.0% in 2018, then grew 23.81% in 2019.
  • Year by year, Non-Current Deferred Tax Liability stood at $115000.0 in 2016, then tumbled by 56.52% to $50000.0 in 2017, then crashed by 58.0% to $21000.0 in 2018, then rose by 23.81% to $26000.0 in 2019.
  • Business Quant data shows Non-Current Deferred Tax Liability for BRTX at $26000.0 in Q4 2019, $21000.0 in Q4 2018, and $50000.0 in Q4 2017.